SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

ASPC is trending amidst intense short squeeze speculation, driven by its extremely low float and reports of high borrow rates. The community is actively discussing massive price targets and frequent trading halts, drawing comparisons to other recent low-float runners while also noting caution around its status as a Chinese SPAC.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing a historic surge, propelled by strong physical demand, notably from China, alongside rising industrial applications in AI and electric vehicles. This rally is generating intense community discussion, with many anticipating a significant short squeeze and the end of prolonged price suppression. However, others remain cautious, debating if the rapid ascent signifies a true repricing or an overextended, speculative move.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a powerful surge to fresh record highs, driven by intensifying geopolitical tensions, ongoing concerns about currency debasement, and widespread expectations for future policy easing. The community is actively debating whether this rally signifies a fundamental shift towards tangible assets amid a weakening dollar and massive government spending, or if it's an overextended move poised for a sharp correction, particularly with many noting gold's outperformance relative to other asset classes.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals (UPC) is drawing significant attention due to its extremely low share float, with the community actively anticipating a potential short squeeze and setting ambitious price targets. Many traders are highlighting the company's substantial cash reserves as a key factor contributing to its perceived undervaluation, while some express caution, warning of potential 'pump and dump' dynamics often seen in similar low-float Chinese stocks.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending due to its specialized AI chips, particularly the energy-efficient Gemini-II APU, which is gaining traction for edge computing in defense and drone applications. The stock is a focal point of intense community debate, with bulls highlighting recent academic validation and potential government contracts as key catalysts, while bears point to commercial struggles and fundamental technology concerns, fueling significant market volatility.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is gaining significant attention, driven by anticipation for its upcoming CES 2026 showcase and the positive impact of its Marigold acquisition, alongside robust financial outlooks. The community widely regards it as an undervalued AI-powered marketing leader, expecting a substantial re-rating fueled by its innovative Athena platform and strategic first-party data capabilities.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility and trending due to an exceptionally high borrow rate, sparking a heated short squeeze discussion. While proponents highlight its low float and unique Mach 2 aerospace technology with potential government contracts, critics point to significant dilution, lack of revenue, and classify it as a speculative 'pump and dump' within the currently active space sector.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is heavily trending amid China's recent sanctions against the company, which many in the community interpret as a significant validation of its role as a critical U.S. defense contractor. This sentiment is amplified by the U.S. government's push to ban foreign-made drones, creating a clear market opportunity for Red Cat's Blue UAS-compliant platforms and anticipated large defense budgets for U.S.-manufactured small drones and unmanned surface vessels. Despite recent price fluctuations, discussion centers on the company's preparedness to meet increased demand through domestic production, fueling expectations for substantial contract awards.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending after releasing preliminary data from its FLAMINGO-01 trial, showing an impressive estimated 80% reduction in breast cancer recurrence rates for patients receiving its GLSI-100 immunotherapy. This positive update, coupled with soaring cost-to-borrow rates and high short interest, has fueled intense community discussion about a potential short squeeze and the stock's significant undervaluation, with many anticipating a major partnership or buyout given its impact on breast cancer treatment.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp (OMER) is trending due to the recent FDA approval of its pioneering drug Yartemlea for transplant-associated thrombotic microangiopathy (TA-TMA), making it the first and only approved treatment for this life-threatening condition across adult and pediatric patients. This significant catalyst, combined with a major licensing deal and a strengthened balance sheet, is fueling widespread bullish sentiment and discussions around substantial upside potential, including a potential short squeeze. The community eagerly anticipates further details on commercialization and pricing from an upcoming conference call.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SOFI  I think we will hover around $27.50 until Jan 7-8. 

SoFi announced a public offering priced at $27.50. In connection with that offering, the company granted the underwriters a 30-day option to purchase up to ~8.18 mil additional shares at the same price ($27.50) to cover excess demand and help stabilize the stock. That 30-day option period starts from the closing of the offering, which was expected to occur around Dec 8, 2025.  

A 30-day option from a Dec 8 closing would expire on or around Jan 7, 2026 (30 days after Dec 8 is Jan 7).  This matches the claim that the underwriters still have until January 7 to exercise that option to buy up to ~8 million more shares at $27.50.  

The underwriters may choose to exercise this option if it benefits them, for example, to cover any short positions or stabilize the stock price as part of the offering process. If they don’t exercise it by the deadline, the option expires and they lose the right to buy those additional shares @ $27.50.

Lo' Ri-Der

KayK

StockTwits for iOS

SoFi Technologies Inc

  I think we will hover around $27.50 until Jan 7-8. 

SoFi announced a public offering priced at $27.50. In connection with that offering, the company granted the underwriters a 30-day option to purchase up to ~8.18 mil additional shares at the same price ($27.50) to cover excess demand and help stabilize the stock. That 30-day option period starts from the closing of the offering, which was expected to occur around Dec 8, 2025.  

A 30-day option from a Dec 8 closing would expire on or around Jan 7, 2026 (30 days after Dec 8 is Jan 7).  This matches the claim that the underwriters still have until January 7 to exercise that option to buy up to ~8 million more shares at $27.50.  

The underwriters may choose to exercise this option if it benefits them, for example, to cover any short positions or stabilize the stock price as part of the offering process. If they don’t exercise it by the deadline, the option expires and they lose the right to buy those additional shares @ $27.50.

Hope

Here is the SEC actual document explaining all of the details. 
https://www.sec.gov/Archives/edgar/data/1818874/000181887425000229/sofidec2025finalprospectus.htm

Document Prospectus Supplement (To prospectus dated July 29, 2025) We are offering 54,545,454 shares of our common stock (the "Offering"). This prospectus supplement updates, amends and supplements the prospectus dated July 29, 2025, which forms a part of our Registration Statement on Form S-3 (Registration No. 333-289046) (the "Prospectus").

Here is the SEC actual document explaining all of the details. 
